Variable | Compound heterozygote | p Value | |||
---|---|---|---|---|---|
Yes | No | ||||
Age (years) | 44.1 (11.3) | 42.4 (13.6) | NS | ||
LVDD (mm) | 63.4 (8.4) | 64.1 (11.3) | NS | ||
LVSD (mm) | 49.7 (12.6) | 52.0 (13.8) | NS | ||
NYHA class | 1.2 (0.4) | 1.6 (0.8) | NS | ||
Peak Vo 2 (ml/kg/min) | 18.2 (9.1) | 21.3 (9.0) | NS | ||
Ethanol5-150 | 9 (90) | 141 (79) | NS | ||
Familial disease | 2 (20) | 57 (28) | NS | ||
Atrial fibrillation | 0 | 33 (19) | NS | ||
Ventricular tachycardia | 3 (30) | 62 (32) | NS | ||
Change in LVDD at follow up (mm) | 1.3 (3.6) | 1.6 (6.6) | NS | ||
Death/transplant | 3 (30) | 50 (25) | NS |
Values are mean (SD) for continuous variables and n (%) for categorical variables.
↵5-150 Consumption of > 5 units/week.
LVDD, left ventricular end diastolic dimension; LVSD, left ventricular end systolic dimension; NYHA, New York Heart Association functional class; Vo 2, oxygen consumption.